Literature DB >> 21626272

Histochemical localization of caldesmon isoforms in colon adenocarcinoma and lymph node metastases.

Christoph Köhler1.   

Abstract

Alternative splicing of the caldesmon gene results in high (h-caldesmon) and low (l-caldesmon) molecular weight isoforms of the cytoskeleton-associated protein caldesmon. h-Caldesmon is predominantly expressed not only in smooth-muscle cells but also in pericryptal fibroblasts in colon. l-Caldesmon is widely expressed and localized in podosomes/invadopodia. Studies with transformed and cancer cell lines suggest that a reduction in l-caldesmon facilitates podosome/invadopodia formation and metastasis. We investigated caldesmon isoforms in colon adenocarcinoma and their lymph node metastases using immunohistochemistry. Caldesmon immunoreactivity of colon adenocarcinoma primary tumors and lymph node metastases was very similar. l-Caldesmon immunoreactivity of cancer epithelial cells in primary tumors and lymph node metastases varied ranging from reduced to stronger as compared to immunoreactivity of normal areas. The variation did not show a consistent relation to the tumor center or invasive margin. While h-caldesmon immunoreactivity of pericryptal fibroblasts and blood vessels in the stroma of primary tumors and lymph node metastases was markedly reduced, cancer-associated fibroblasts and blood vessels in the stroma were strongly immunoreactive for l-caldesmon. Our results show a differential behavior of h- and l-caldesmon isoforms in epithelium and stroma of colon adenocarcinoma and lymph node metastases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21626272     DOI: 10.1007/s00428-011-1091-0

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  48 in total

Review 1.  Stem cell plasticity and tumour formation.

Authors:  Malcolm R Alison; Matthew J Lovell; Natalie C Direkze; Nicholas A Wright; Richard Poulsom
Journal:  Eur J Cancer       Date:  2006-05-02       Impact factor: 9.162

Review 2.  Caldesmon, a novel regulatory protein in smooth muscle and nonmuscle actomyosin systems.

Authors:  K Sobue; J R Sellers
Journal:  J Biol Chem       Date:  1991-07-05       Impact factor: 5.157

Review 3.  Invadopodia: specialized cell structures for cancer invasion.

Authors:  Alissa M Weaver
Journal:  Clin Exp Metastasis       Date:  2006-07-09       Impact factor: 5.150

4.  Monoclonal antibodies against caldesmon, a Ca++/calmodulin- and actin-binding protein of smooth muscle and nonmuscle cells.

Authors:  J J Lin; J L Lin; E J Davis-Nanthakumar; D Lourim
Journal:  Hybridoma       Date:  1988-06

5.  Stromal cell changes in human colorectal adenomas and carcinomas. An ultrastructural study of fibroblasts, myofibroblasts, and smooth muscle cells.

Authors:  H Ohtani; N Sasano
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1983

6.  Phosphorylated l-caldesmon is involved in disassembly of actin stress fibers and postmitotic spreading.

Authors:  Jolanta Kordowska; Tracy Hetrick; Leonard P Adam; C-L Albert Wang
Journal:  Exp Cell Res       Date:  2005-11-11       Impact factor: 3.905

7.  Differential expression of Hela-type caldesmon in tumour neovascularization: a new marker of angiogenic endothelial cells.

Authors:  Ping-Pin Zheng; M van der Weiden; Johan M Kros
Journal:  J Pathol       Date:  2005-02       Impact factor: 7.996

8.  Reduced expression of actin-binding proteins, h-caldesmon and calponin h1, in the vascular smooth muscle inside melanoma lesions: an adverse prognostic factor for malignant melanoma.

Authors:  Y Koganehira; M Takeoka; T Ehara; K Sasaki; H Murata; T Saida; S Taniguchi
Journal:  Br J Dermatol       Date:  2003-05       Impact factor: 9.302

9.  Caldesmon suppresses cancer cell invasion by regulating podosome/invadopodium formation.

Authors:  T Yoshio; T Morita; Y Kimura; M Tsujii; N Hayashi; K Sobue
Journal:  FEBS Lett       Date:  2007-07-05       Impact factor: 4.124

10.  Morphological and biochemical analyses of contractile proteins (actin, myosin, caldesmon and tropomyosin) in normal and transformed cells.

Authors:  J Tanaka; T Watanabe; N Nakamura; K Sobue
Journal:  J Cell Sci       Date:  1993-02       Impact factor: 5.285

View more
  4 in total

1.  An integrative framework identifies alternative splicing events in colorectal cancer development.

Authors:  Andrea Bisognin; Silvia Pizzini; Lisa Perilli; Giovanni Esposito; Simone Mocellin; Donato Nitti; Paola Zanovello; Stefania Bortoluzzi; Susanna Mandruzzato
Journal:  Mol Oncol       Date:  2013-10-19       Impact factor: 6.603

2.  Bayesian penalized cumulative logit model for high-dimensional data with an ordinal response.

Authors:  Yiran Zhang; Kellie J Archer
Journal:  Stat Med       Date:  2020-12-18       Impact factor: 2.497

3.  Construction and prognostic analysis of miRNA-mRNA regulatory network in liver metastasis from colorectal cancer.

Authors:  Ruyun Cai; Qian Lu; Da Wang
Journal:  World J Surg Oncol       Date:  2021-01-04       Impact factor: 2.754

Review 4.  Cyclooxygenase 2-Regulated Genes an Alternative Avenue to the Development of New Therapeutic Drugs for Colorectal Cancer.

Authors:  Alicia M Hidalgo-Estévez; Konstantinos Stamatakis; Marta Jiménez-Martínez; Ricardo López-Pérez; Manuel Fresno
Journal:  Front Pharmacol       Date:  2020-04-29       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.